Source: Health Canada shortage reports · Updated Oct 16, 2026
Fluvoxamine has no current shortage reported in Canada. It has been in shortage before; the history is below.
An SSRI antidepressant used to treat obsessive-compulsive disorder and depression.
Products affected
0 / 10
Reports on file
47
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
APO-FLUVOXAMINE
50MG · TABLET · APOTEX INC
DIN 02231329 · ended Oct 15, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-FLUVOXAMINE
50MG · TABLET · TEVA CANADA LIMITED
DIN 02255529 · ended Sep 24, 2026 · Disruption of the manufacture of the drug.
Resolved
LUVOX
50MG · TABLET · BGP PHARMA ULC
DIN 01919342 · ended Jan 21, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-FLUVOXAMINE
100MG · TABLET · TEVA CANADA LIMITED
DIN 02255537 · ended Jan 20, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-FLUVOXAMINE
100MG · TABLET · APOTEX INC
DIN 02231330 · ended May 16, 2024 · Disruption of the manufacture of the drug.
Resolved
ACT FLUVOXAMINE
100MG · TABLET · TEVA CANADA LIMITED
DIN 02255537 · ended May 8, 2024 · Disruption of the manufacture of the drug.
Resolved
ACT FLUVOXAMINE
50MG · TABLET · TEVA CANADA LIMITED
DIN 02255529 · ended Mar 6, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-FLUVOXAMINE
100MG · TABLET · APOTEX INC
DIN 02231330 · ended Jan 18, 2024 · Disruption of the manufacture of the drug.
Resolved
LUVOX
50MG · TABLET · BGP PHARMA ULC
DIN 01919342 · ended Jan 9, 2024 · Disruption of the manufacture of the drug.
Resolved
ACT FLUVOXAMINE
100MG · TABLET · TEVA CANADA LIMITED
DIN 02255537 · ended Oct 18, 2023 · Disruption of the manufacture of the drug.
Discontinued
FLUVOXAMINE-100
100MG · TABLET · PRO DOC LIMITEE
DIN 02236754
Discontinued
FLUVOXAMINE-50
50MG · TABLET · PRO DOC LIMITEE
DIN 02236753
Showing 12 of 47 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Fluvoxamine. Health Canada has 47 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Fluvoxamine is classified under “ANTIDEPRESSANTS” (ATC N06AB).
Recent changes
Oct 16, 2026
Shortage resolved
Oct 2, 2026
Estimated end date pushed back : Oct 2, 2026 → Oct 16, 2026
Sep 25, 2026
Estimated end date pushed back : Sep 25, 2026 → Oct 2, 2026
Sep 25, 2026
Shortage resolved
Sep 18, 2026
New report filed
Common questions
What is Fluvoxamine used for?
An SSRI antidepressant used to treat obsessive-compulsive disorder and depression.
When will Fluvoxamine be back in stock in Canada?
Fluvoxamine has no active shortage; supply is normal per Health Canada reports.
Why is Fluvoxamine in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.